596.94MMarket Cap-5418P/E (TTM)
11.730High11.130Low237.31KVolume11.260Open11.310Pre Close2.70MTurnover0.64%Turnover RatioLossP/E (Static)52.97MShares17.58052wk High2.57P/B415.30MFloat Cap3.77052wk Low--Dividend TTM36.85MShs Float71.580Historical High--Div YieldTTM5.31%Amplitude3.350Historical Low11.380Avg Price1Lot Size
Stoke Therapeutics Stock Forum
In the rapidly evolving world of biotechnology, companies like Stoke Therapeutics are pioneering groundbreaking treatments that could potentially change the lives of patients with severe diseases. The recent buzz surrounding Stoke Therapeutics, particularly their work on an anti-epilepsy drug, STK-001, underscores the transformative potential of RNA-based therapies in addres...
No comment yet